Bassan; Merav

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bassan; Merav.The latest application filed is for "pridopidine for treating huntington's disease".

Company Profile

4.8.17

Bassan; Merav - Netanya IL
Bassan; Merav - Hod Hasharon IL
Bassan; Merav - Givat-Poleg IL
Bassan; Merav - Natanya IL
Bassan; Merav - Natania IL
BASSAN, MERAV - RAMAT HASHARON IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pridopidine For Treating Huntington's Disease App 20210308115 - Bassan; Merav ; et al.	2021-10-07
Pridopidine for treating huntington's disease Grant 11,090,297 - Bassan , et al. August 17, 2	2021-08-17
Use of pridopidine to improve cognitive function and for treating Alzheimer's disease Grant 10,603,311 - Geva , et al.	2020-03-31
Use Of Pridopidine To Improve Cognitive Function And For Treating Alzheimer's Disease App 20200093813 - Geva; Michal ; et al.	2020-03-26
Pridopidine For Treating Huntington's Disease App 20190350915 - BASSAN; Merav ; et al.	2019-11-21
Modified Release Formulations Of Pridopidine App 20190209542 - Licht; Daniella ; et al.	2019-07-11
Use of pridopidine for treating Huntington's disease Grant 10,322,119 - Bassan , et al.	2019-06-18
Use Of Pridopidine To Improve Cognitive Function And For Treating Alzheimer's Disease App 20160243098 - Geva; Michal ; et al.	2016-08-25
Modified Release Formulations Of Pridopidine App 20150202302 - Licht; Daniella ; et al.	2015-07-23
Use Of High Dose Pridopidine For Treating Huntington's Disease App 20140378508 - Bassan; Merav ; et al.	2014-12-25
Fusion Of Human Growth Hormone And Albumin Formulation And Uses Thereof App 20140162954 - Brown; Kurt ; et al.	2014-06-12
Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides Grant 7,863,247 - Brenneman , et al. January 4, 2	2011-01-04
Method for treatment of amyotrophic lateral sclerosis using talampanel App 20090258863 - Ben-Ami; Miri ; et al.	2009-10-15
Activity Dependent Neurotrophic Factor Iii (adnf Iii) App 20090124543 - Gozes; Illana ; et al.	2009-05-14
Activity dependent neurotrophic factor III (ADNF III) Grant 7,264,947 - Gozes , et al. September 4, 2	2007-09-04
Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides Grant 6,933,277 - Brenneman , et al. August 23, 2	2005-08-23
Activity dependent neurotrophic factor III (ADNF III) App 20040053313 - Gozes, Illana ; et al.	2004-03-18
Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides Grant 6,649,411 - Gozes , et al. November 18, 2	2003-11-18
Activity dependent neurotrophic factor III (ADNF III) Grant 6,613,740 - Gozes , et al. September 2, 2	2003-09-02
Methods Of Inhibiting Cancer Cells With Adnf Iii Antisense Oligonucleotides App 20030036521 - GOZES, ILLANA ; et al.	2003-02-20
Prevention Of Fetal Alcohol Syndrome And Neuronal Cell Death With Adnf Polypeptides App 20020111301 - BRENNEMAN, DOUGLAS E. ; et al.	2002-08-15

Company Registrations

SEC

0001792702

Bassan Merav

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.